Surrey Memorial Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Atrial fibrillation1 trial
• Heart failure1 trial
• Lung cancer1 trial
• Migraine1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Alliance for Clinical Trials in Oncology1 trial
• Boehringer Ingelheim1 trial
• Dr George Medvedev1 trial

Running trials

• Enrolling by invitation

  Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context

  NCT06428838· Phase 3· Dr George Medvedev· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

  NCT00499330· Alliance for Clinical Trials in Oncology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Migraine1 recruiting

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source